Mainz Biomed
(NASDAQ) MYNZ
Mainz Biomed Financials at a Glance
Market Cap
$43.26M
Revenue (TTM)
$1.43M
Net Income (TTM)
-$37.86M
EPS (TTM)
$0.00
P/E Ratio
-0.03
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.78
Volume
1,560,346.613
Open
$1.93
Price
$1.78
Volume
1,560,346.613
Open
$1.93
Previous Close
$1.90
Daily Range
$1.71 - $1.99
52-Week Range
$0.30 - $4.93
Estimated Earnings Date
Apr 14, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.78
Volume
1,560,346.613
Open
$1.93
Previous Close
$1.90
Daily Range
$1.71 - $1.99
52-Week Range
$0.30 - $4.93
Estimated Earnings Date
Apr 14, 2026
MYNZ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mainz Biomed
Industry
Biotechnology
Sector
Health CareEmployees
13
CEO
Guido Baechler
Website
mainzbiomed.comHeadquarters
Mainz, 55129, DE
MYNZ Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-27%
Net Income Margin
-29%
Return on Equity
0%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-33.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$43.26M
Shares Outstanding
22.77M
Volume
1.56M
Avg. Volume
17.74M
Financials (TTM)
Gross Profit
-$225.93K
Operating Income
-$13.50M
EBITDA
-$12.88M
Operating Cash Flow
-$10.98M
Capital Expenditure
-$1.22K
Free Cash Flow
-$10.98M
Cash & ST Invst.
$889.09K
Total Debt
$2.57M
Mainz Biomed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$250.36K
+16.6%
Gross Profit
$84.41K
+109.7%
Gross Margin
33.72%
N/A
Market Cap
$43.26M
N/A
Market Cap/Employee
$2.28M
N/A
Employees
19
N/A
Net Income
-$7.87M
-51.8%
EBITDA
-$5.14M
+59.2%
Quarterly Fundamentals
Total Cash
$889.09K
-87.4%
Total Debt
$2.57M
-65.3%
Accounts Receivable
$110.89K
-68.7%
Inventory
$216.89K
-64.7%
Long Term Debt
$992.48K
-54.8%
Short Term Debt
$1.58M
-69.8%
Return on Assets
-1.09%
N/A
Return on Invested Capital
-1.70%
N/A
Free Cash Flow
-$4.46M
+9.2%
Operating Cash Flow
-$4.46M
+4.1%